Lazar S. Popovic

Novi Sad, VO, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer.

Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer.

Journal: Cancers

Published: December 07, 2025

Complementary therapies in early breast cancer: Oncologists' evidence-based decisions in a Southeast European vignette survey.

Complementary therapies in early breast cancer: Oncologists' evidence-based decisions in a Southeast European vignette survey.

Journal: Biomolecules & biomedicine

Published: October 22, 2025

Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results.

Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results.

Journal: Breast (Edinburgh, Scotland)

Published: October 08, 2025

Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study.

Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study.

Journal: Histopathology

Published: August 01, 2025

Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset.

Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset.

Journal: Clinical & experimental metastasis

Published: March 11, 2025

Treatment Sequencing in Metastatic HR+/HER2- Breast Cancer: A Delphi Consensus.

Treatment Sequencing in Metastatic HR+/HER2- Breast Cancer: A Delphi Consensus.

Journal: Cancers

Published: March 07, 2025

LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements.

LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements.

Journal: Food chemistry: X

Published: February 11, 2025

Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience.

Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience.

Journal: Cancer medicine

Published: August 13, 2024

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab.

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab.

Journal: Scientific reports

Published: July 22, 2024

Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Journal: Diabetes research and clinical practice

Published: May 10, 2024

The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs.

The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs.

Journal: Journal of medical economics

Published: April 19, 2024

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Journal: ESMO open

Published: March 22, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026